EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of migraine treatments with reduced ischemic stroke risk: Evidence from two large‐scale real‐world data analyses

Eugene Jeong iD, Mulubrhan F Mogos, You Chen iD

Headache: The Journal of Head and Face Pain · 2025

DOI: 10.1111/head.14918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2025. Verfasst von Eugene Jeong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Ischemic Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NLM NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the risk of ischemic stroke in patients with migraine treated with first‐line medications, including valproate, topiramate, metoprolol, timolol, or propranolol, versus those not receiving these treatments, using data from two large electronic health records datasets.

Background

The impact of first‐line migraine medications on ischemic stroke risk in patients with migraine remains uncertain, highlighting the need for further investigation.

Methods

We conducted a retrospective case–control study using data from Vanderbilt University Medical Center (VUMC) and the All of Us Research Program. Cases were patients with a primary ischemic stroke diagnosis after their first migraine diagnosis, while controls had no ischemic stroke following their initial migraine diagnosis.

Results

In the VUMC database, 356 cases and 15,231 controls were identified; the All of Us database included 256 cases and 6590 controls. Propranolol was the only medication significantly associated with a reduced risk of ischemic stroke in female patients with migraine (VUMC: adjusted odds ratio [aOR] 0.55, 95% confidence interval [CI] 0.33–0.86, p = 0.013; All of Us: aOR 0.41, 95% CI 0.19–0.77, p = 0.010), particularly in those with migraine without aura (VUMC: aOR 0.53, 95% CI 0.29–0.90, p = 0.027; All of Us: aOR 0.28, 95% CI 0.10–0.62, p = 0.006). The Cox model showed lower ischemic stroke rates in propranolol‐treated female patients with migraine at 10 years in the VUMC data (adjusted hazard ratio [aHR] 0.45, 95% CI 0.24–0.83; p = 0.011, log‐rank p < 0.001) and 10 years in the All of Us data (aHR 0.29, 95% CI 0.09–0.87; p = 0.048, log‐rank p = 0.003).

Conclusions

Among various migraine treatments, propranolol was notably associated with a significant reduction in ischemic stroke risk among female patients with migraine, particularly those without aura. These findings suggest a potential dual benefit of propranolol in managing migraine and reducing stroke risk, highlighting the need for further prospective studies to confirm these results and potentially inform clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersIschemic StrokeHumansFemaleRetrospective StudiesMaleMiddle AgedCase-Control StudiesAdultPropranololDatabases, FactualTopiramateValproic AcidAgedMetoprololTimololElectronic Health Records

Stichwörter der Autor:innen

electronic health recordsischemic strokemigrainemigraine treatmentspropranolol

Substanzen

PropranololTopiramateValproic AcidMetoprololTimolol

Autor:innen und Institutionen

  • Department of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • School of Nursing, Vanderbilt University, Nashville, Tennessee, USA.
  • Department of Computer Science, School of Engineering, Vanderbilt University, Nashville, Tennessee, USA.

ORCID-Profile: Eugene Jeong, You Chen

Förderung

  • NLM NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences of the National Institutes of Health
  • Vanderbilt University

Zitieren

APA

Jeong, E., Mogos, M. F., & Chen, Y. (2025). Association of migraine treatments with reduced ischemic stroke risk: Evidence from two large‐scale real‐world data analyses. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14918

Vancouver

Jeong E, Mogos MF, Chen Y. Association of migraine treatments with reduced ischemic stroke risk: Evidence from two large‐scale real‐world data analyses. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14918

BibTeX
@article{Jeong2025,
  author = {Jeong, Eugene and Mogos, Mulubrhan F and Chen, You},
  title = {Association of migraine treatments with reduced ischemic stroke risk: Evidence from two large‐scale real‐world data analyses},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2025},
  doi = {10.1111/head.14918}
}
Kostenlos starten →